Siemens Healthineers and Vivolight Medical Collaborate to Launch DSA-OCT Integrated Multi-Modal Diagnostic and Treatment Platform, Ushering in a New Era of Intelligent Cath Labs
Siemens Healthineers and Vivolight Medical Collaborate to Launch DSA-OCT Integrated Multi-Modal Diagnostic and Treatment Platform, Ushering in a New Era of Intelligent Cath Labs
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10589/242645_c4e0376094c59a4e_001full.jpg
Zhongshan Hospital, established in 1937, is one of China's top-tier comprehensive tertiary hospitals and serves as the National Clinical Research Center for Radiology and Therapy. Its cardiology department, a national key clinical specialty, has consistently ranked among the top three in the "China Hospital Specialty Reputation Ranking" for cardiovascular diseases, with an annual volume of over 21,000 interventional procedures.
The ARTIS icono floor innovatively integrates DSA and OCT technologies into a single platform, combining the "two eyes" of cardiologists. This integration provides comprehensive vascular information from anatomical to functional perspectives during coronary heart disease treatment, offering a full range of vascular data for percutaneous coronary intervention (PCI) procedures. This enhances diagnostic efficiency and enables more precise PCI strategies.
With the global aging population accelerating, the burden of cardiovascular diseases is increasing. By 2030, it is estimated that 16% of the global population will be over 65 years old, and the number of coronary heart disease patients may exceed 250 million. In this context, the demand for PCI procedures is surging, while traditional DSA technology struggles to meet the needs of precision diagnostics. The introduction of OCT fills this gap, and the emergence of the DSA-OCT integrated platform has fundamentally restructured the workflow of interventional procedures, bringing significant clinical benefits exceeding 40%.
Siemens Healthineers and Vivolight Medical Collaborate to Launch DSA-OCT Integrated Multi-Modal Diagnostic and Treatment Platform, Ushering in a New Era of Intelligent Cath Labs
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10589/242645_c4e0376094c59a4e_002full.jpg
The ARTIS icono floor made its global debut at the China International Import Expo (CIIE) in Shanghai in November 2024. Within less than a month, it was installed at its first hospital and received high praise from physicians upon initial use.
"Interventional cardiology has evolved over the past 40 years. With advancements in technology and devices, we are now pursuing the ultimate goal of combining traditional coronary angiography with new functional and structural assessment technologies. Siemens Healthineers and Vivolight Medical's integration of DSA and OCT provides patients with more precise treatment, offering greater clinical benefits." commented Academician Ge Junbo (Academician of the Chinese Academy of Sciences and Director of the Cardiology Department at Zhongshan Hospital, Fudan University).
Cannot view this video? Visit:
https://www.youtube.com/watch?v=K2ti_nn3uW8
Vivolight Medical, the company behind this integrated OCT system, is based in Shenzhen, China, and is a pioneering medical device company focused on the integration of laser diagnostic and therapeutic technologies with minimally invasive interventional procedures. Its system innovatively combines imaging, OCT-FFR functional assessment, and plaque diagnostics into one system, significantly enhancing the convenience of obtaining multi-dimensional vascular information in clinical settings while greatly reducing catheter costs.
In the future, Vivolight Medical plans to leverage artificial intelligence technology based on intravascular imaging data. Through big data and machine learning algorithms, the company aims to provide evidence-based procedure guidance strategies for physicians. This will enable faster adoption of advanced interventional techniques and offer comprehensive diagnostic support, ushering in a new era of intelligent Cath Labs.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
01-08-2025
- Globe and Mail
Unlocking ROI in Medical Imaging: The Strategic Growth of the Global MRI Systems Market
"The key players profiled in the MRI systems market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan), Fonar Corporation (US)" Browse 226 market data Tables and 56 Figures spread through 259 Pages and in-depth TOC on "MRI Systems Market by Architecture (Open, Closed), Field Strength (High Field MRI Systems & Low Field MRI Systems), Design (Portable MRI Systems, Fixed/Stationary MRI Systems), End User (Hospitals, Diagnostic Clinic), Region - Global Forecast to 2030 Why MRI Systems Are a Smart Long-Term Investment As the healthcare industry undergoes a paradigm shift toward precision medicine and value-based care, Magnetic Resonance Imaging (MRI) has emerged as a cornerstone of diagnostic excellence. Forecasted to grow from USD 6.15 billion in 2024 to USD 9.01 billion by 2030, the MRI systems market offers robust opportunities for healthcare providers, OEMs, and strategic investors alike. For C-level executives, the MRI market represents more than just imaging hardware—it's a long-term investment in AI-enabled diagnostics, faster clinical workflows, and improved patient outcomes. With a CAGR of 6.5%, the sector is primed for innovation-led expansion and solid ROI. Market Snapshot: A Growing Industry with Predictable ROI 2024 Market Size: USD 6.15 Billion 2025 Projection: USD 6.56 Billion 2030 Forecast: USD 9.01 Billion CAGR: 6.5% (2024–2030) Driving Forces: Rise in neurological and musculoskeletal conditions Global aging population Increasing oncology imaging requirements Advancements in ultra-high-field MRI Favorable regulatory and reimbursement environments High-Value Applications: Brain & Neurological MRI Lead the Charge According to market research, brain and neurological MRI is the largest and fastest-growing application segment. This growth is driven by the surge in neurodegenerative disorders such as Alzheimer's, Parkinson's, epilepsy, and stroke. For hospital executives and diagnostic center owners, investing in neuro-MRI systems ensures better diagnostic precision, faster patient throughput, and enhanced clinical reputation—all critical ROI levers. Key ROI Insights: Faster diagnosis → Reduced inpatient days High diagnostic accuracy → Lower misdiagnosis risk Software upgrades → Extended equipment lifecycle Field Strength Matters: Ultra-High-Field MRI Is the Future The market is categorized by field strength: Low-to-mid-field High & very-high-field Ultra-high-field Among these, ultra-high-field MRI is experiencing the highest CAGR. These systems offer: Superior Signal-to-Noise Ratio (SNR) Enhanced contrast resolution Exceptional neuro and cardiovascular imaging As hospitals seek competitive clinical differentiation, ultra-high-field MRI investments will become a strategic priority. End User Analysis: Why Hospitals Dominate the Market Hospitals are currently the largest adopters of MRI systems and are expected to continue dominating. Their edge lies in: Access to capital investment budgets Integrated multi-specialty diagnostic care Alignment with value-based reimbursement models For CFOs and CIOs, the integration of MRI into enterprise imaging architecture ensures: Optimized resource allocation Predictable revenue from advanced imaging Better data utilization for AI algorithms Geographical Insights: North America Sets the Pace North America leads the global MRI systems market due to: Cutting-edge healthcare infrastructure Strong presence of OEMs and distributors Favorable regulatory and R&D support Healthcare providers in the U.S. are focusing on: High-throughput MRI centers Remote scanning capabilities Integration with AI and cloud-based radiology tools For OEMs and med-tech investors, the region is ripe for partnerships, pilot programs, and acquisitions. Request Sample Pages : Top Companies to Watch: Strategic Moves from Market Leaders 1. Siemens Healthineers (Germany) A frontrunner with a global manufacturing and R&D footprint, Siemens has deep investments in molecular imaging, AI-driven diagnostics, and portable MRI innovations. 2. GE HealthCare (US) GE's strategic growth is powered by inorganic acquisitions and global reach. Their solutions span molecular imaging, cardiac MRI, and biopharma integration. 3. Philips (Netherlands) Philips focuses on image-guided therapy, ultrasound integration, and cloud-connected platforms. Their Diagnosis & Treatment segment is a growth engine for MRI innovation. Other notable players: Canon Inc. (Japan) FUJIFILM Corporation (Japan) Fonar Corporation (US) Esaote S.p.A (Italy) United Imaging Healthcare (China) Innovation Trends: The Future of MRI is AI, Portability & Cloud Emerging innovation themes include: AI-enhanced image reconstruction Low-helium or helium-free systems Cloud-integrated radiology reporting Portable and point-of-care MRI Strategic Implications for C-suite: AI & ML tools embedded into MRI workflows can increase operational efficiency by 20–30% Cloud PACS integration ensures interoperability across multisite locations Portability introduces new revenue streams in mobile diagnostics and remote care What This Means for Healthcare Decision-Makers For CIOs, CFOs, and Clinical Executives, investing in MRI systems is no longer about hardware—it's a holistic ecosystem decision involving software, analytics, AI, and patient experience. Key Questions Executives Are Asking: How does MRI investment impact long-term patient retention and referral growth? Can we bundle MRI services with AI diagnostics for higher margins? What's the total cost of ownership (TCO) versus projected operational ROI? Conclusion: MRI Systems as a Strategic Differentiator in 2030 As demand for advanced diagnostic capabilities surges globally, MRI systems stand out as a high-impact, high-yield investment. With expanding clinical applications, regulatory support, and innovation momentum, this is an opportunity that healthcare leaders cannot afford to overlook. Whether you're managing hospital procurement, evaluating M&A options in the imaging space, or scaling a diagnostic chain, the MRI systems market offers sustainable ROI, technological resilience, and significant growth potential through 2030. For more information, Inquire Now!
Canada News.Net
30-07-2025
- Canada News.Net
Big Tech pushback grows as EU tightens grip on online politics
BRUSSELS, Belgium: Meta Platforms has announced it will stop running political, electoral, and social issue advertisements on its platforms across the European Union starting in early October 2025. The tech giant cited "legal uncertainties" surrounding new EU regulations as the reason for its decision, marking a significant shift in how political content will be managed on platforms like Facebook and Instagram during upcoming European elections. The move aligns with a similar step taken by Google's parent company, Alphabet, in November last year, highlighting growing resistance among major U.S. tech firms to tighter EU regulation. Both companies are responding to the European Union's new Transparency and Targeting of Political Advertising (TTPA) regulation, set to take effect on October 10, 2025. The regulation, designed to curb disinformation and foreign meddling in elections, introduces strict requirements for digital platforms. Under the new law, political ads must be clearly labeled, identify the sponsors, disclose spending, and specify which elections they are targeting. Companies that fail to comply face penalties of up to 6% of their annual global revenue. In a blog post, Meta acknowledged that the decision to halt political advertising in the EU was difficult but necessary. "This is a difficult decision—one we've taken in response to the EU's incoming Transparency and Targeting of Political Advertising regulation, which introduces significant operational challenges and legal uncertainties," the company wrote. Meta also warned that the new rules could have negative consequences for European citizens. "We believe that personalized ads are critical to a wide range of advertisers, including those engaged in campaigns to inform voters about important social issues," Meta said. "Regulations like the TTPA significantly undermine our ability to offer these services, not only impacting the effectiveness of advertisers' outreach but also the ability of voters to access comprehensive information." The European Commission has resisted such arguments, asserting that greater transparency is essential to protecting democratic institutions. The EU is already investigating Meta's platforms—Facebook and Instagram—for alleged failures to combat disinformation and misleading advertising ahead of the 2024 European Parliament elections. That investigation falls under the broader Digital Services Act (DSA), which mandates that large online platforms take stronger action against harmful and illegal content or face severe penalties, including fines of up to 6% of global turnover. Meta is not alone in facing scrutiny. ByteDance's TikTok is also under investigation for its handling of election-related misinformation, particularly during Romania's presidential elections last November. The combined pressure from the TTPA and DSA reflects the EU's broader strategy to assert greater control over digital platforms and hold tech companies accountable for content shared on their networks, especially content related to democratic processes. As the October 10 deadline approaches, Meta's decision to withdraw from political and social issue advertising in the EU raises concerns among campaigners and civil society groups that rely on digital outreach to inform voters and shape public debate. It also sets the stage for a more regulated and, potentially, more opaque digital election landscape in Europe.
Cision Canada
30-07-2025
- Cision Canada
Specsavers to Open 111 New Optical Locations in Loblaw Grocery Stores Across Canada Français
Specsavers locations will open in select Loblaw grocery stores across Canada – including in Loblaws, Real Canadian Superstore and Zehrs stores – while maintaining seamless continuity for customers and patients, and significantly expanding access to advanced eye care services including Optical Coherence Tomography (OCT) technology. The expansion also represents Specsavers' entry into five new provinces — New Brunswick, Newfoundland and Labrador, Nova Scotia, Prince Edward Island, and Saskatchewan — and one new territory, Yukon, while strengthening its presence in British Columbia, Alberta, Manitoba, and Ontario. "This expansion represents a pivotal moment for eye care accessibility in Canada," said Bill Moir, Managing Director of Specsavers Canada. "By opening 111 new locations within trusted Loblaw locations, we're fundamentally improving how Canadians access the eye care they deserve. Our mission has always been to change lives through better sight; we believe expert eye care and quality eyewear should be affordable for all. We are now able to expand that mission across the country, ensuring that more families can access comprehensive optical services in the communities where they already shop." New Specsavers locations will operate within existing Loblaws stores, providing customers and patients with convenient access to comprehensive eye examinations, prescription eyewear, contact lenses, and specialized eye care services. All locations will be staffed by qualified independent optometrists and opticians. "Theodore & Pringle was born from the belief that eye care should be convenient and affordable for everyone," said Irene Doody, Head of Optical, Loblaw Companies Limited. "Specsavers' reputation for accessible eye care aligns perfectly with our purpose - to help Canadians live life well. Specsavers will provide a seamless transition for our optical customers while introducing them to a trusted global leader in eye care." The first wave of new Specsavers locations within Loblaw stores is scheduled to open in September 2025, with additional locations following throughout the remainder of the year. About Specsavers Specsavers is an optometrist-owned business that entered the Canadian market in late 2021. Since then, over 150 locations have opened across the country, in B.C., Alberta, Ontario, and Manitoba. As part of Specsavers' commitment to accessible eyecare, Specsavers equips every location with optical coherence tomography (OCT) technology, which helps optometrists to detect sight-threatening conditions, such as age-related macular degeneration, glaucoma and diabetic eye disease, in their earliest stages. Founded in the UK over 40 years ago by optometrist husband-and-wife team, Doug and Mary Perkins, there are now more than 2,700 Specsavers healthcare businesses globally, serving over 44 million patients and customers. Specsavers is driven by its purpose of "changing lives through better sight" and aims to transform the way Canadians experience eyecare by offering exceptional service, advanced clinical equipment and quality eyewear. For more information, please visit About Loblaw Companies Limited Loblaw is Canada's food and pharmacy leader, and the nation's largest retailer. Loblaw provides Canadians with grocery, pharmacy, and healthcare services, other health and beauty products, apparel, general merchandise, financial services and wireless mobile products and services. With more than 2,800 locations, Loblaw, its franchisees and Associate-owners employ more than 220,000 full- and part-time employees, making it one of Canada's largest private sector employers. Loblaw's purpose – Live Life Well ® – puts first the needs and well-being of Canadians who make one billion transactions annually in the company's stores. Loblaw is positioned to meet and exceed those needs in many ways: convenient locations; more than 1,100 grocery stores that span the value spectrum from discount to specialty; full-service pharmacies at nearly 1,400 Shoppers Drug Mart ® and Pharmaprix ® locations and in close to 500 grocery stores; PC Financial ® services; Joe Fresh ® fashion and family apparel; and four of Canada's top-consumer brands in Life Brand ®, Farmer's Market™, no name ® and President's Choice ®. For more information, visit Loblaw's website at and Loblaw's issuer profile at
